FDA Investigator Joy Rkozlowski Klena

Joy Rkozlowski Klena has conducted inspections on 132 sites in 2 countries as of 18 Mar 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

132

Last Inspection Date:

18 Mar 2008

Investigator Role:

FDA Investigation Participant

Redica ID:

100005913

Countries of Inspections:

United States of America, Canada

FDA Investigators that have inspected at least one site in common with Joy Rkozlowski Klena:

Addam S Reynolds, Adetutu M Gidado, Alanna L Mussawwir Bias, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Ana S Cabrera, Anastasia I Offordile, Andrew R Wasko, Ankur C Patel, Ann Marie Montemurro, Ann Marie Schofield, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Anthony M Criscuolo, Jr, Arsen Karapetyan, Ashley A Mutawakkil, Ashley J Burns, Atul J Agrawal, Azeezat M Lawal, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Bei Yu, Binh T Nguyen, Brett R Havranek, Brian D Nicholson, Byungja E Marciante, Cara M Minelli, Carla A Norris, Cary Greene, Cassandra L Abellard, Charles A Snipes, PhD, Charles J Chacko, Charles M Edwards, Christian F Gomez Lugo, Christina K Theodorou, Christina P Burkhart, Christine M Cerenzio, Christopher T Middendorf, Claire M Minden, Constantin Y Philopoulos, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Dale A Nyberg, Dan Grabicki, Daniel J Grabicki, Daniel J Min, David A Oluwo, David E Bailey, Dawn L Wydner, Deborah B Goffman, Deborah B Nixon, Denise M Visco, Investigator, Devaughn Edwards, Devon Jenkins, Dinesh Kumar, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Elaine E Gilfillan, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Frank J Marciniak, Frank Wackes, Fred Razzaghi, Frederick F Razzaghi, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Graeme E Price, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Israel Santiago, OCM, Jacqueline Mdiaz Albertini, James L Finn, James R Birkenstamm, James R Evans, Jamie L Dion, Janet A Rajan, Jawaid Hamid, Jay B Shah, Jean Blackston Hill, Jean M Kelahan, Jean M Mulinde, MD, Jeffrey J Ebersole, Jennifer Macmillan, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Joanne Heim, Jogy George, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, José E Meléndez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joshua C Schafer, Juanita P Versace, Julie D Bringger, Justine Tomasso, Karen E D'orazio, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kelly I Anderson, Kevin Obrien, Kevin P Foley, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystyna M Kitson, Laishan L Lam, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Laurel A Beer, Lauren L Vajo, Lawrence R Johnson, Li Li, Liatte Kreuger, PharmD, Lily Y Koo, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa M Bellows, Logan T Williams, Loretta Nemchik, Lori M Newman, LT Colin E Tack, BSE, LT Tamara J Henderson, Luis A Dasta, Maotang Zhou, PhD, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Marie T Falcone, Matthew A Spataro, Maureen A Wentzel, Mayar M Mussa, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Merril E Racke, Meyer J Slobotsky, Michael R Klapal, Michael Rosner, Michael Serrano, Michelle M Parisi, Mihaela Jason, Mihaly S Ligmond, Mindy M Chou, Monika Borkowska, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj R Mehta, PhD, Noreen Muñiz, Odera I Ekwunife, Omotunde O Osunsanmi, Patricia H Dlugosz, Patrick C Klotzbuecher, Patrick L Wisor, Paul L Bellamy, Paula J Bretz, Peter R Lenahan, Phares O Okelo, Prabhu P Raju, Pratibha Bhat, Rafeeq A Habeeb, Ralph A Erickson, Ramanda C Gregory, Raymond L Cheung, Rebecca Rodriguez, Regina T Brown, Richard J Muzeni, Richard W Thornton, Ricki A Chase, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert Sharpnack, Robert W Calais, Robin P Mathew, Rochelle L Cross, Rosario D'costa, Rose Ljean Mary, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra Kershaw, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Sayyem H Akbar, Sean G Casey, Sean R Marcsisin, Shelby N Turner, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai I Davis, Stelios C Tsinontides, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven P Eastham, Suchan Kim, Susan M Halsted, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Teresa I Navas, Thai D Truong, Thomas J Arista, Tonia F Bernard, Travis R Hunt, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vincent F Cafiso, Vlada Matusovsky, Wayne J Meyer, William A Warnick, William R Chang, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhaohui Ye, Zhijin Chen, Zhongren Wu

Joy Rkozlowski Klena's Documents

Publish Date	Document Type	Title
July, 2006	FDA 483	Micro Chem Laboratories - Form 483, 2006-07-20
August, 2006	EIR	OHM LABORATORIES INC. - EIR, 2006-08-16
September, 2001	EIR	Kinder Morgan Liquids Terminals, LLC - EIR, 2001-09-06
June, 2006	EIR	OHM LABORATORIES INC. - EIR, 2006-06-28
March, 2001	FDA 483	Glaxo Smithkline - Form 483, 2001-03-15
June, 2003	FDA 483	A. Pharma Usa, Inc. - Form 483, 2003-06-02
August, 2004	FDA 483	DSHealthcare Inc. - Form 483, 2004-08-05
November, 2002	EIR	Cosette Pharmaceuticals, Inc. - EIR, 2002-11-13
July, 2007	EIR	Vantage Specialty Ingredients, Inc - EIR, 2007-07-17
January, 2000	FDA 483	Enzon Pharmaceuticals, Inc - Form 483, 2000-01-20
February, 2002	EIR	Merck, Inc. - EIR, 2002-02-08
March, 2000	EIR	FAR Specialty Products, Inc. - EIR, 2000-03-16
February, 2007	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2007-02-06
January, 2001	FDA 483	Merck & Co., Inc. - Form 483, 2001-01-19
September, 2002	EIR	Able Laboratories Inc. - EIR, 2002-09-18
February, 2002	FDA 483 Response	Merck, Inc. - Form 483R, 2002-03-27
January, 2004	FDA 483	Jubilant HollisterStier General Partnership. - Form 483, 2004-01-20
May, 2000	FDA 483	OHM LABORATORIES INC. - Form 483, 2000-05-09
September, 2003	FDA 483 Response	Hoffmann La Roche Inc - Form 483R, 2003-09-30
January, 2008	FDA 483	Nexmed USA Inc. - Form 483, 2008-01-15
April, 2003	FDA 483	Halo Pharmaceuticals Inc. - Form 483, 2003-04-10
April, 2003	FDA 483 Response	Halo Pharmaceuticals Inc. - Form 483R, 2003-04-25
September, 2003	EIR	Hoffmann La Roche Inc - EIR, 2003-09-10
September, 2006	FDA 483	Apicore US LLC - Form 483, 2006-09-25
June, 2006	FDA 483 Response	OHM LABORATORIES INC. - Form 483R, 2006-06-28
May, 2004	EIR	Enzon Pharmaceuticals, Inc - EIR, 2004-05-24
December, 2003	FDA 483	Actavis Elizabeth LLC - Form 483, 2003-12-15
September, 2003	FDA 483	Hoffmann La Roche Inc - Form 483, 2003-09-10
May, 2004	EIR	IAM ACQUISITIONS, LLC - EIR, 2004-05-27
April, 2001	EIR	Guardian Drug Company - EIR, 2001-04-09
April, 2003	EIR	Halo Pharmaceuticals Inc. - EIR, 2003-04-10
June, 2006	FDA 483 Response	OHM LABORATORIES INC. - Form 483R, 2006-07-31
July, 2003	FDA 483	Enzon Pharmaceuticals, Inc - Form 483, 2003-07-10
January, 2007	EIR	Cordis Corporation - EIR, 2007-01-12
June, 2003	FDA 483	Perritt Laboratories, Inc - Form 483, 2003-06-11
January, 2005	EIR	Able Laboratories, Inc. - EIR, 2005-01-05
June, 2006	FDA 483	OHM LABORATORIES INC. - Form 483, 2006-06-19
July, 2003	EIR	GE Healthcare Inc. - EIR, 2003-07-23
November, 2002	FDA 483	Cosette Pharmaceuticals, Inc. - Form 483, 2002-11-13
October, 2001	FDA 483	Duramed Pharmaceuticals, Inc. - Form 483, 2001-10-12
June, 2003	EIR	Perritt Laboratories, Inc - EIR, 2003-06-11
August, 2004	EIR	Par Pharmaceutical Companies, Inc. - EIR, 2004-09-17
January, 2001	FDA 483 Response	Merck, Inc. - Form 483R, 2001-02-16
September, 2006	EIR	OHM LABORATORIES INC. - EIR, 2006-09-06
February, 2005	FDA 483 Response	Able Laboratories Inc. - Form 483R, 2005-03-21
November, 2007	FDA 483	OHM LABORATORIES INC. - Form 483, 2007-11-26
February, 2004	EIR	Glaxo Smith Kline - EIR, 2004-02-25
February, 2005	FDA 483	Able Laboratories Inc. - Form 483, 2005-02-22
January, 2004	FDA 483 Response	Jubilant HollisterStier General Partnership. - Form 483R, 2004-02-11
August, 2001	FDA 483	Enzon Pharmaceuticals, Inc - Form 483, 2001-08-02
April, 2006	FDA 483	Janssen Pharmaceuticals Inc. - Form 483, 2006-04-11
February, 2005	EIR	Able Laboratories Inc. - EIR, 2005-02-22
March, 2008	FDA 483	Advent Pharmaceuticals Inc. - Form 483, 2008-03-05
April, 2002	FDA 483 Response	Reheis Inc - Form 483R, 2002-05-10
October, 2000	EIR	Duramed Pharmaceuticals Inc - EIR, 2000-10-19
June, 2003	EIR	A. Pharma Usa, Inc. - EIR, 2003-06-02
July, 2003	EIR	Enzon Pharmaceuticals, Inc - EIR, 2003-07-10
October, 2003	FDA 483	VILS Pharma Coating LLC - Form 483, 2003-10-22
April, 2001	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2001-04-24
May, 2000	EIR	OHM LABORATORIES INC. - EIR, 2000-05-09
August, 2002	FDA 483	Scientech Laboratories, Inc. - Form 483, 2002-08-07
June, 2002	EIR	Avantor Performance Materials, LLC - EIR, 2002-06-27
January, 2002	EIR	Able Laboratories Inc. - EIR, 2002-01-10
August, 2000	FDA 483	Organon USA Inc. - Form 483, 2000-08-23
June, 2006	EIR	OHM LABORATORIES INC. - EIR, 2006-06-19
August, 2000	FDA 483 Response	Organon USA Inc. - Form 483R, 2000-09-07
February, 2002	FDA 483	Merck, Inc. - Form 483, 2002-02-08
March, 2004	EIR	Baxter Healthcare Corporation - EIR, 2004-03-11
January, 2004	EIR	Jubilant HollisterStier General Partnership. - EIR, 2004-02-11
December, 2001	FDA 483	Hoffmann La Roche Inc - Form 483, 2001-12-12
October, 2000	FDA 483	Duramed Pharmaceuticals, Inc. - Form 483, 2000-10-19
May, 2003	EIR	BRACCO DIAGNOSTICS INC - EIR, 2003-05-01
November, 2006	FDA 483	Medico Labs, Inc. - Form 483, 2006-11-16
October, 2003	EIR	VILS Pharma Coating LLC - EIR, 2003-10-22
March, 2007	EIR	ACINO PRODUCTS LIMITED LIABILITY COMPANY - EIR, 2007-03-12
June, 2004	EIR	Merck, Inc. - EIR, 2004-06-07
August, 2001	EIR	Able Laboratories Inc. - EIR, 2001-08-22
June, 2000	EIR	New Chemic (U.S.), Inc. - EIR, 2000-06-14
August, 2002	FDA 483 Response	Scientech Laboratories, Inc. - Form 483R, 2002-09-04
February, 2000	EIR	Bristol-Myers Squibb Company - EIR, 2000-02-02
July, 2004	FDA 483	Somerville Acquisitions Co., Inc. - Form 483, 2004-07-21
March, 2000	FDA 483	FAR Specialty Products, Inc. - Form 483, 2000-03-16
October, 2001	EIR	Duramed Pharmaceuticals Inc - EIR, 2001-10-12
February, 2002	FDA 483	Tevco Enterprises, Inc. - Form 483, 2002-02-27
February, 2004	FDA 483	Glaxo Smith Kline - Form 483, 2004-02-25
December, 2003	EIR	Actavis Elizabeth LLC - EIR, 2003-12-15
January, 2001	FDA 483	Merck, Inc. - Form 483, 2001-01-19
December, 2001	EIR	Hoffmann La Roche Inc - EIR, 2001-12-12
November, 2007	EIR	OHM LABORATORIES INC. - EIR, 2007-11-26
April, 2006	EIR	Ortho Clinical Diagnostics - EIR, 2006-04-11
April, 2006	EIR	Ohm Laboratories, Inc. - EIR, 2006-04-24
April, 2002	EIR	Reheis Inc - EIR, 2002-04-22
November, 2007	FDA 483 Response	OHM LABORATORIES INC. - Form 483R, 2007-12-17
December, 2003	FDA 483 Response	Actavis Elizabeth LLC - Form 483R, 2004-01-09
August, 2007	FDA 483	Sunrise Pharmaceutical Inc - Form 483, 2007-08-20
January, 2001	EIR	Merck, Inc. - EIR, 2001-01-19
May, 2006	FDA 483	Ohm Laboratories Inc - Form 483, 2006-05-01
July, 2003	FDA 483 Response	Enzon Pharmaceuticals, Inc - Form 483R, 2004-05-10
October, 2003	EIR	Rand Diversified LLC - EIR, 2003-10-15
June, 2006	FDA 483	OHM LABORATORIES INC. - Form 483, 2006-06-28
July, 2004	EIR	Somerville Acquisitions Co., Inc. - EIR, 2004-09-01
June, 2002	FDA 483 Response	Avantor Performance Materials, LLC - Form 483R, 2002-07-24
April, 2001	FDA 483	Guardian Drug Company - Form 483, 2001-04-09
April, 2002	FDA 483	Reheis Inc - Form 483, 2002-04-22
March, 2007	FDA 483	ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2007-03-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more